Silverton Natalie A, Hall Isaac E, Melendez Natalia P, Harris Brad, Harley Jackson S, Parry Samuel R, Lofgren Lars R, Stoddard Gregory J, Hoareau Guillaume L, Kuck Kai
Department of Anesthesiology, University of Utah, Salt Lake City, UT.
Department of Internal Medicine, Division of Nephrology and Hypertension, University of Utah, School of Medicine, Salt Lake City, UT.
J Cardiothorac Vasc Anesth. 2021 Jun;35(6):1691-1700. doi: 10.1053/j.jvca.2020.12.026. Epub 2021 Feb 4.
To evaluate the association of intraoperative urinary biomarker excretion during cardiac surgery and the subsequent development of acute kidney injury (AKI).
Prospective, nonrandomized, observational study.
Single tertiary-level, university-affiliated hospital.
Ninety patients undergoing cardiac surgery with cardiopulmonary bypass (CPB).
None.
Urinary samples were collected every 30 minutes intraoperatively and then at four, 12, and 24 hours after CPB. Samples were measured for interleukin 18 (IL-18), kidney injury molecule-1 (KIM1), and creatinine concentrations. Urinary biomarker excretion (raw and indexed to creatinine) for four intraoperative and three postoperative points were compared between patients with and those without subsequent AKI defined by increased serum creatinine concentration ≥0.3 mg/dL within the first 48 hours or ≥1.5 times baseline within seven days. Raw and indexed median IL-18 values were similar between AKI groups at all intraoperative points, but became significantly different at 12 hours after CPB. Raw and indexed median KIM1 values were significantly different between AKI groups at multiple intraoperative points and at four and 12 hours after CPB. During intraoperative and postoperative points, patients in the fourth quartile of KIM1 excretion had greater AKI incidence and longer intensive care and hospital lengths of stay than those in the first quartile. Only postoperatively did the differences in these outcomes between the fourth and first quartile of IL-18 excretion occur.
Intraoperative KIM1 but not IL-18 excretion was associated with postoperative development of AKI.
评估心脏手术期间术中尿生物标志物排泄与随后急性肾损伤(AKI)发生之间的关联。
前瞻性、非随机、观察性研究。
单一的三级大学附属医院。
90例行体外循环心脏手术的患者。
无。
术中每30分钟收集一次尿样,然后在体外循环后4小时、12小时和24小时收集。检测样本中的白细胞介素18(IL-18)、肾损伤分子-1(KIM1)和肌酐浓度。比较有和没有随后发生AKI的患者在术中4个时间点和术后3个时间点的尿生物标志物排泄情况(原始值和肌酐校正值),AKI定义为血清肌酐浓度在最初48小时内升高≥0.3mg/dL或在7天内≥基线值的1.5倍。在所有术中时间点,AKI组之间的原始和肌酐校正后IL-18中位数相似,但在体外循环后12小时有显著差异。在多个术中时间点以及体外循环后4小时和12小时,AKI组之间的原始和肌酐校正后KIM1中位数有显著差异。在术中和术后各时间点,KIM1排泄处于第四个四分位数的患者比处于第一个四分位数的患者有更高的AKI发生率,以及更长的重症监护和住院时间。只有在术后,IL-18排泄处于第四个和第一个四分位数的患者在这些结果上才出现差异。
术中KIM1而非IL-18排泄与术后AKI的发生有关。